These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23956169)

  • 21. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.
    Pelat C; Falchi A; Carrat F; Mosnier A; Bonmarin I; Turbelin C; Vaux S; van der Werf S; Cohen JM; Lina B; Blanchon T; Hanslik T
    PLoS One; 2011 May; 6(5):e19621. PubMed ID: 21573005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
    Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.
    Mahmud SM; Van Caeseele P; Hammond G; Kurbis C; Hilderman T; Elliott L
    Emerg Infect Dis; 2012 May; 18(5):801-10. PubMed ID: 22516189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
    Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
    Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network.
    Puig-Barberà J; Mira-Iglesias A; Burtseva E; Cowling BJ; Serhat U; Ruiz-Palacios GM; Launay O; Kyncl J; Koul P; Siqueira MM; Sominina A;
    BMC Infect Dis; 2019 May; 19(1):415. PubMed ID: 31088481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary analysis of influenza A(H1N1)pdm09 during the pandemic and post-pandemic period in Pakistan.
    Badar N; Salman M; Aamir UB; Ansari J; Ranjha MA; Khan MA; Ikram A; Nisar N; Mushtaq N; Mirza HA
    J Infect Public Health; 2020 Mar; 13(3):407-413. PubMed ID: 31000492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.
    Borse RH; Shrestha SS; Fiore AE; Atkins CY; Singleton JA; Furlow C; Meltzer MI
    Emerg Infect Dis; 2013 Mar; 19(3):439-48. PubMed ID: 23622679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.
    Ortqvist A; Bennet R; Rinder MR; Lindblad H; Eriksson M
    Vaccine; 2012 Aug; 30(39):5699-702. PubMed ID: 22819987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19.
    Chiu SS; Kwan MY; Feng S; Chan EL; Chua H; Wong JS; Peiris JM; Cowling BJ
    Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
    Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
    Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.
    Steens A; Wijnans EG; Dieleman JP; Sturkenboom MC; van der Sande MA; van der Hoek W
    BMC Infect Dis; 2011 Jul; 11():196. PubMed ID: 21767348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of influenza in the post-pandemic phase: Clinical features in hospitalized patients with influenza A (H1N1) pdm09 and H3N2 viruses, during 2013 in Santa Fe, Argentina.
    Kusznierz G; Carolina C; Manuel RJ; Sergio L; Lucila O; Julio B; Mirta V; Pedro M; Graciana M; Andrea U; Elsa Z
    J Med Virol; 2017 Jul; 89(7):1186-1191. PubMed ID: 28004402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Return of pandemic H1N1 influenza virus.
    Sherbany H; McCauley J; Meningher T; Hindiyeh M; Dichtiar R; Markovich MP; Mendelson E; Mandelboim M
    BMC Infect Dis; 2014 Dec; 14():710. PubMed ID: 25551676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.